Morgan Stanley Rates CG Oncology Shares Overweight on Positive Outcomes
February 21, 2024 : In a move that signals optimism for the future of CG Oncology, Morgan Stanley initiated coverage of the company’s shares with an “Overweight”
February 21, 2024 : In a move that signals optimism for the future of CG Oncology, Morgan Stanley initiated coverage of the company’s shares with an “Overweight”